Weekly cisplatin fails to reduce acute toxicity in advanced head and neck cancer
Physicians typically use either a higher dose of cisplatin given every three weeks or a lower dose given weekly in combination with radiation to treat locally advanced head and neck cancer.
Read original article on The Medical News →Related news
-
Petrelintide produces double-digit weight loss with fewer side effects
United Kingdom
-
Flexible work and fair pay could help create healthier jobs, researchers say
United Kingdom
-
Researchers found a curious mitochondrial pattern in people who moved more
United Kingdom
-
People with evening chronotypes face higher risk of early disability retirement
United Kingdom
-
Cold temperatures may raise eye pressure in glaucoma patients
United Kingdom
-
Weekly isometric exercise may maintain short-term blood pressure reductions
United Kingdom
-
$5.7 million NIH grant supports research on why lean people develop insulin resistance
United Kingdom
-
Maternal depression linked to neurodevelopmental disorders in children
United Kingdom